Lipid Nano-System Based Topical Drug Delivery for Management of Rheumatoid Arthritis: An Overview
The overall purpose of rheumatoid arthritis (RA) treatment is to give symptomatic alleviation; there is no recognized cure for RA. Frequent use of potent drugs like non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs), lead to various adverse effects and...
Main Authors: | Komal Diliprao Dhule, Tanaji Dilip Nandgude |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2023-11-01
|
Series: | Advanced Pharmaceutical Bulletin |
Subjects: | |
Online Access: | https://apb.tbzmed.ac.ir/PDF/apb-13-663.pdf |
Similar Items
-
Spectroscopic method to estimate 3-Acetyl-11-keto-β-boswellic acid in complex lipid nanocarriers and skin matrices
by: Sakshi Priya, et al.
Published: (2024-01-01) -
Co-Delivery of Aceclofenac and Methotrexate Nanoparticles Presents an Effective Treatment for Rheumatoid Arthritis
by: Negi S, et al.
Published: (2024-03-01) -
Lipid metabolism and rheumatoid arthritis
by: Qian Lei, et al.
Published: (2023-05-01) -
Lipid mediators obtained from docosahexaenoic acid by soybean lipoxygenase attenuate RANKL-induced osteoclast differentiation and rheumatoid arthritis
by: Yan Su, et al.
Published: (2024-02-01) -
A Study on the Relationship between Lipid Profile and Rheumatoid Arthritis Activity
by: Mansour salesi, et al.
Published: (2012-02-01)